Matches in Nanopublications for { ?s ?p "[As Cox-2 is known to inhibit radiotherapy responses in SCCHN patients, data indicate an additional mechanism through which DeltaNp63 acts to promote cell survival and influence therapeutic response of SCCHN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP222225.RAPoJkeXhZWRCQHZLl36WmcJ5FuBoJjmOrgznyI0rAEXo130_assertion description "[As Cox-2 is known to inhibit radiotherapy responses in SCCHN patients, data indicate an additional mechanism through which DeltaNp63 acts to promote cell survival and influence therapeutic response of SCCHN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP222225.RAPoJkeXhZWRCQHZLl36WmcJ5FuBoJjmOrgznyI0rAEXo130_provenance.
- assertion description "[As Cox-2 is known to inhibit radiotherapy responses in SCCHN patients, data indicate an additional mechanism through which DeltaNp63 acts to promote cell survival and influence therapeutic response of SCCHN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP734508.RAdl1HuBR2tzjEMkQ1Rn9lTeX2FYBEEG3rFgXzjN6OhEY130_assertion description "[As Cox-2 is known to inhibit radiotherapy responses in SCCHN patients, data indicate an additional mechanism through which DeltaNp63 acts to promote cell survival and influence therapeutic response of SCCHN.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734508.RAdl1HuBR2tzjEMkQ1Rn9lTeX2FYBEEG3rFgXzjN6OhEY130_provenance.